Adverum Biotechnologies Inc (NASDAQ:ADVM) is set to release its earnings data on Monday, November 6th. Analysts expect Adverum Biotechnologies to post earnings of ($0.29) per share for the quarter.

Shares of Adverum Biotechnologies Inc (NASDAQ ADVM) opened at $3.25 on Friday. Adverum Biotechnologies Inc has a 52 week low of $2.40 and a 52 week high of $4.20.

ILLEGAL ACTIVITY WARNING: “Adverum Biotechnologies Inc (ADVM) Scheduled to Post Earnings on Monday” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/adverum-biotechnologies-inc-advm-scheduled-to-post-earnings-on-monday/1676946.html.

A number of equities analysts have issued reports on the company. ValuEngine downgraded Adverum Biotechnologies from a “sell” rating to a “strong sell” rating in a research report on Friday, September 1st. Zacks Investment Research downgraded Adverum Biotechnologies from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Chardan Capital reiterated a “hold” rating and set a $3.50 price target on shares of Adverum Biotechnologies in a research report on Tuesday, September 5th. Finally, Raymond James Financial, Inc. assumed coverage on Adverum Biotechnologies in a research report on Thursday, October 12th. They set an “outperform” rating and a $6.00 price target on the stock.

Adverum Biotechnologies Company Profile

Adverum Biotechnologies, Inc, formerly Avalanche Biotechnologies, Inc, is a gene therapy company. The Company is engaged in discovering and developing medicines to patients suffering from chronic or debilitating disease. The Company operates and manages its business in the segment of developing and commercializing gene therapeutics.

Earnings History for Adverum Biotechnologies (NASDAQ:ADVM)

Receive News & Ratings for Adverum Biotechnologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adverum Biotechnologies Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.